 | • レポートコード：MRC-IM30360 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年6億ドルであった世界の嚢胞性線維症治療薬市場規模が2027年には103億ドルに達し、予測期間中、年平均9.4％成長すると予測しています。本調査レポートでは、嚢胞性線維症治療薬の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、医薬品クラス別（膵臓酵素サプリメント、粘液溶解剤、気管支拡張薬、CFTR修飾薬、その他）分析、薬物分子種類別（低分子医薬品、バイオ医薬品）分析、投与経路別（経口、吸入）分析、エンドユーザー別（病院、診療所、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、AbbVie Inc., Alaxia, Alcresta Therapeutics Inc., Allergan, AstraZeneca, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の嚢胞性線維症治療薬市場規模：医薬品クラス別 - 膵臓酵素サプリメントの市場規模 - 粘液溶解剤の市場規模 - 気管支拡張薬の市場規模 - CFTR修飾薬の市場規模 - その他嚢胞性線維症治療薬の市場規模 ・世界の嚢胞性線維症治療薬市場規模：薬物分子種類別 - 低分子医薬品における市場規模 - バイオ医薬品における市場規模 ・世界の嚢胞性線維症治療薬市場規模：投与経路別 - 経口型嚢胞性線維症治療薬の市場規模 - 吸入型嚢胞性線維症治療薬の市場規模 ・世界の嚢胞性線維症治療薬市場規模：エンドユーザー別 - 病院における市場規模 - 診療所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の嚢胞性線維症治療薬市場規模：地域別 - 北米の嚢胞性線維症治療薬市場規模 - アジアの嚢胞性線維症治療薬市場規模 - 欧州の嚢胞性線維症治療薬市場規模 - 中南米の嚢胞性線維症治療薬市場規模 - 中東・アフリカの嚢胞性線維症治療薬市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global cystic fibrosis therapeutics market size reached US$ 6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2027, exhibiting a growth rate (CAGR) of 9.4% during 2022-2027.
Cystic fibrosis (CF) is a rare and progressive genetic disorder that is characterized by an abnormal movement of sodium and chloride across the gastrointestinal and respiratory tracts. This disorder can cause the development of viscous secretions in the lungs, pancreas, intestines and liver. The management and treatment of CF involve physical therapy, gene therapy, physiotherapy and nutritional support. Along with this, gene therapy and medicinal drugs, such as pancreatic enzyme supplements, mucolytics, bronchodilators and cystic fibrosis transmembrane conductance regulator (CFTR) modulators are also used for targeting cellular interactomes and symptomatic improvement. These drugs can be administered to the patient orally or by inhalation.
The rising incidence of cystic fibrosis across the globe, along with improvements in the diagnostic technologies of the disorder, is one of the key factors driving the growth of the market. Furthermore, widespread adoption of cystic fibrosis transmembrane conductance (CFTR) modulators as a treatment alternative is also providing a boost to the market growth. CFTRs are configured to regulate the flow of water and chloride through cell linings of the lungs and other organs and correct the malfunctioning protein in the body. Additionally, various technological advancements, such as the development of personalized drug therapy, molecular prosthetics and innovative drugs with improved efficacy, are acting as another growth-inducing factor. Other factors, including rising healthcare expenditures, increasing health consciousness, and awareness regarding the available treatment options for cystic fibrosis, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cystic fibrosis therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, drug molecule type, route of administration and end-user.
Breakup by Drug Class:
Pancreatic Enzyme Supplements
Mucolytics
Bronchodilators
CFTR Modulators
Antibiotics
Others
Breakup by Drug Molecule Type:
Small Molecule Drugs
Biologics
Breakup by Route of Administration:
Oral Drugs
Inhaled Drugs
Breakup by End-User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Alaxia, Alcresta Therapeutics Inc., Allergan, AstraZeneca, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., etc.
Key Questions Answered in This Report:
How has the global cystic fibrosis therapeutics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global cystic fibrosis therapeutics market?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the drug molecule type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cystic fibrosis therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cystic Fibrosis Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Pancreatic Enzyme Supplements
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Mucolytics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Bronchodilators
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 CFTR Modulators
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Antibiotics
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Drug Molecule Type
7.1 Small Molecule Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biologics
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Inhaled Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End-User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbvie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Alaxia
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Alcresta Therapeutics Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Allergan
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 AstraZeneca
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche Ltd
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Gilead Sciences Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck & Co., Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Novartis AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Teva Pharmaceutical Industries Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Vertex Pharmaceuticals Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Figure 2: Global: Cystic Fibrosis Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Class (in %), 2021
Figure 4: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Molecule Type (in %), 2021
Figure 5: Global: Cystic Fibrosis Therapeutics Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Cystic Fibrosis Therapeutics Market: Breakup by End-User (in %), 2021
Figure 7: Global: Cystic Fibrosis Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cystic Fibrosis Therapeutics (Biologics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cystic Fibrosis Therapeutics (Biologics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cystic Fibrosis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cystic Fibrosis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Cystic Fibrosis Therapeutics (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Cystic Fibrosis Therapeutics (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia Pacific: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia Pacific: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Global: Cystic Fibrosis Therapeutics Industry: SWOT Analysis
Figure 84: Global: Cystic Fibrosis Therapeutics Industry: Value Chain Analysis
Figure 85: Global: Cystic Fibrosis Therapeutics Industry: Porter’s Five Forces Analysis
• 日本語訳：嚢胞性線維症治療薬の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30360 ▷ お問い合わせ（見積依頼・ご注文・質問）